Overview of harm reduction in prisons in seven European countries. Sander G, Scandurra A, Kamenska A, MacNamara C, Kalpaki C, Bessa CF, Laso GN, Parisi G, Varley L, Wolny M, Moudatsou M, Pontes NH, Mannix-McNamara P, Libianchi S, Antypas T.&nbs…

Opioid substitution treatment drastically reduces the risk of mortality after release from prison. However, providers have reported that some patients prefer to cease treatment prior to release back into the community. Why do some incarcerated indiv…

First Dutch national guidelines--pharmacological care for detained opioid addicts. Arends MT, De Haan HA, Van 't Hoff GI. Int J Prison Health. 2009;5(4):192-200. doi: 10.1080/17449200903343167. Abstract https://www.ncbi.nlm.nih.gov/pubme…

CONTRIBUTION CRUCIALE DE LA COUR EUROPENNE DES DROITS DE L’HOMME A L’ACCES AUX SOINS DES PERSONNES DETENUES DÉPENDANTES DES OIOÏDES. Äußerst wichtiger Beitrag des Europäischen Gerichtshofs für Menschenre…

Germany violated the rights of a heroin addict by denying him access to his drug substitution treatment while in prison, the European Court of Human Rights has ruled. (deutsche welle, 01.09.2016) http://www.dw.com/en/addict-wins-court-battle-over-a…

Häftling gewinnt vor Gericht: Deutschland vom Menschenrechtsgerichtshof verurteilt / Prof. Dr. Heino Stöver vom Institut für Suchtforschung der Frankfurt UAS nimmt Stellung zum Urteil. (idw, 06.09.2016) https://idw-online.de/de/news6…